TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.

Ursula A Matulonis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.